Nov

3

Not Just Another HGH Study

November 3, 2008 |

 New clinical results on a recent human growth hormone (hgh) study will be released next week:

Ambrx Inc. today announced the scheduled presentation of data from a Phase I/II clinical trial of ARX201, the company’s long-acting human growth hormone (hGH) analogue developed in collaboration with Merck Serono, at the International Congress of Endocrinology meeting in Rio de Janeiro. Andrew R. Hoffman, M.D., Professor of Medicine and Vice President of Academic Affairs at Stanford University, will present the clinical results as part of an oral presentation at 9:30 AM local time (GMT -3 / 7:30 AM EST) on November 12, 2008.

There are safe alternatives to injectible hgh, like an hgh oral spray available without a prescription. Click here for more information!

Read the entire hgh article


Comments

Name (required)

Email (required)

Website

Speak your mind

Comments are closed.